Skip to main content
. Author manuscript; available in PMC: 2016 Mar 25.
Published in final edited form as: Small. 2014 Oct 29;11(12):1453–1459. doi: 10.1002/smll.201402179

Figure 1.

Figure 1

IFN-gamma producing splenocytes in ELISPOT assay after treatment with various conditions. Mice were injected subcutaneously on both flanks on day 0 with a total dose of 2×1011 AuNP-OVA and 1012 AuNP-CpG, or the equivalent of at most 50 μg OVA and approximately 4.7 μg CpG. The dose was repeated on day 10, and the spleens were harvested on day 17. *, p<0.02.